Resarch on new Schiff bases with antiblastic activity. Carcinostatic activities of 3-p-(2',5'-dimethoxy-4'-(N,N-bis( -chloroethyl)-amino)benzylideneamino)phenyl-2-oxazolidinone (GEA 29  = BAY a 5850).
D000588:Amines / Q000138:chemical synthesis / Q000627:therapeutic use*; D000814:Aniline Compounds / Q000138:chemical synthesis / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000627:therapeutic use*; D002279:Carcinoma 256, Walker / Q000188:drug therapy*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D055598:Chemical Phenomena; D002621:Chemistry; D006224:Cricetinae; D004920:Erythropoiesis; D006410:Hematopoiesis; D007938:Leukemia / Q000188:drug therapy*; D007962:Leukocytes; D051379:Mice; D009368:Neoplasm Transplantation; D009588:Nitrogen Mustard Compounds / Q000138:chemical synthesis / Q000627:therapeutic use; D010080:Oxazoles / Q000138:chemical synthesis / Q000627:therapeutic use*; D051381:Rats; D012190:Retroviridae; D012510:Sarcoma 180 / Q000188:drug therapy*; D012513:Sarcoma, Experimental / Q000188:drug therapy*; D012545:Schiff Bases / Q000138:chemical synthesis / Q000627:therapeutic use
D000588:Amines; D000814:Aniline Compounds; D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D010080:Oxazoles; D012545:Schiff Bases